Adlai Nortye (ANL) Other Non-Current Assets (2022 - 2024)
Adlai Nortye's (ANL) quarterly Other Non-Current Assets came in at $31.8 million in Q2 2024, up 28.17% on a QoQ basis from $24.8 million in Q4 2023.
Adlai Nortye (ANL) Other Non-Current Assets (2022 - 2024) Analysis & Trends
Adlai Nortye (ANL) has 3 years of Other Non-Current Assets data on file, last reported at $31.8 million in Q2 2024.
- On a quarterly basis, Other Non-Current Assets changed N/A year-over-year to $31.8 million in Q2 2024; TTM through Jun 2024 was $31.8 million, a N/A change from a year earlier, with the FY2023 full-year figure at $24.8 million, up 7499.08% from the prior year.
- Other Non-Current Assets for Q2 2024 stood at $31.8 million, up from $24.8 million in the prior quarter.
- Over the last five years, Other Non-Current Assets for ANL reached as high as $31.8 million in Q2 2024 and fell as low as $327000.0 in Q4 2022.
- Historically, Other Non-Current Assets has averaged $19.0 million across 3 years, with a median of $24.8 million in 2023.
- On a YoY basis, Other Non-Current Assets climbed as much as 7499.08% in 2023 and fell as far as 7499.08% in 2023.
- Year by year, Other Non-Current Assets stood at $327000.0 in 2022, then jumped by 7499.08% to $24.8 million in 2023, then grew by 28.17% to $31.8 million in 2024.
- Per Business Quant data, the three most recent Other Non-Current Assets figures were $31.8 million in Q2 2024, $24.8 million in Q4 2023, and $327000.0 in Q4 2022.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | 1.02 Mn |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | 60,000.00 |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 104.24 Mn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 1.26 Bn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | 2.13 Bn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | 289.41 Mn |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | 124.00 Mn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | 14.48 Mn |
| 10 | Adlai Nortye | 1.16 Bn | 1.15 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2024 | 31.85 Mn |
| Dec 31, 2023 | 24.85 Mn |
| Dec 31, 2022 | 327,000.00 |